Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 3Phase 1 2Phase 2/3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 9Gastrointestinal 4Dermatologic 3Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Breast 1

Conditions

Melanoma 3Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 16Cyclophosphamide 11fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 10Cyclosporine 10Photochemotherapy 9Biopsy 9Whole-Body Irradiation 8Standard of Care 8Radiotherapy 8Educational Status 8Surgical Procedures, Operative 7Radiosurgery 7Mycophenolic Acid 7Early Intervention, Educational 7Aminolevulinic Acid 7Tomography, Optical Coherence 6Surveys and Questionnaires 6Psychiatric Rehabilitation 6Practice Guidelines as Topic 6Methods 6Melphalan 6Filgrastim 6Sentinel Lymph Node Biopsy 5Magnetic Resonance Spectroscopy 5Busulfan 5Antilymphocyte Serum 5methyl 5-aminolevulinate 4Therapeutics 4Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Immunotherapy × Dermatologic × Clear all
NCT07407166 2026-02-17

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

Institute of Oncology Ljubljana

Phase NA Recruiting
40 enrolled
Dermatologic

Melanoma

NCT06146920 2025-11-18

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Massachusetts General Hospital

Phase NA Active not recruiting
39 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05478876 2024-08-21

CYCLE

CNAO National Center of Oncological Hadrontherapy

Phase NA Recruiting
9 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡